Literature DB >> 16433209

Influence of age and gender on serum eotaxin concentration in healthy and allergic people.

T Targowski1, K Jahnz-Rózyk, T Plusa, E Glodzinska-Wyszogrodzka.   

Abstract

BACKGROUND: Eotaxin is one of the important chemokines that modulate allergic inflammation. In many studies a correlation between an elevated serum concentration of eotaxin, allergen exposure and allergic symptoms has been confirmed. Influence of other factors on eotaxin concentration is feebly recognized. We made an attempt to assess the influence of age and gender on the serum eotaxin level in healthy people and in patients with intermittent IgE-mediated rhinoconjunctivitis (AR).
METHODS: The serum eotaxin level was measured in 245 healthy people and 241 patients with AR before the pollen season with the ELISA technique (KITS, R&D USA, pg/ml). The parametric tests and linear regression analysis were used in statistical calculations.
RESULTS: There were no differences between the allergic group and the healthy one in the mean age (accordingly: 31.3 +/- 11.6 yrs. vs. 31.6 +/- 12.5 yrs.; p=0.1) and the mean serum eotaxin content (118.1 +/- 44.9 pg/ml vs. 116.3 +/- 34.8 pg/ml; p=0.3). A significant relationship between the serum eotaxin level, gender and age was revealed in both groups and regression models were derived. A linear correlation between age (semi-partial correlation beta = 0.47, p = 0.0000001) and gender (semi-partial correlation beta = 0.3, p = 0.0000001), on the one side, and the serum eotaxin level, on the other, was found for the allergic people. In the control group a similar relationship between the serum eotaxin level and age (semi-partial correlation coefficient beta = 0.63, p = 0.0000001) and gender (semi-partial correlation factor beta = 0.23, p = 0.000006) was observed.
CONCLUSIONS: Age and sex significantly influence the serum eotaxin content in healthy people and patients with IgE-mediated rhinoconjunctivitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16433209

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  9 in total

1.  The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications.

Authors:  Tomer Adar; Shimon Shteingart; Ami Ben-Ya'acov; Ariella Bar-Gill Shitrit; Dan M Livovsky; Shimrit Shmorak; Mahmud Mahamid; Bernardo Melamud; Fiona Vernea; Eran Goldin
Journal:  Dig Dis Sci       Date:  2016-02-13       Impact factor: 3.199

2.  CCL11 (Eotaxin-1) Levels Predict Long-Term Functional Outcomes in Patients Following Ischemic Stroke.

Authors:  Meaghan Roy-O'Reilly; Rodney M Ritzel; Sarah E Conway; Ilene Staff; Gilbert Fortunato; Louise D McCullough
Journal:  Transl Stroke Res       Date:  2017-06-21       Impact factor: 6.829

3.  Construction and analysis of the NCI-EDRN breast cancer reference set for circulating markers of disease.

Authors:  Jeffrey R Marks; Karen S Anderson; Paul Engstrom; Andrew K Godwin; Laura J Esserman; Gary Longton; Edwin S Iversen; Anu Mathew; Christos Patriotis; Margaret S Pepe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-03       Impact factor: 4.254

4.  Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients.

Authors:  Ziemowit Zietkowski; Maria M Tomasiak-Lozowska; Roman Skiepko; Elzbieta Zietkowska; Anna Bodzenta-Lukaszyk
Journal:  Respir Res       Date:  2010-08-12

Review 5.  The systemic environment: at the interface of aging and adult neurogenesis.

Authors:  Lucas K Smith; Charles W White; Saul A Villeda
Journal:  Cell Tissue Res       Date:  2017-11-09       Impact factor: 5.249

6.  Plasma Chemokines in Patients with Alcohol Use Disorders: Association of CCL11 (Eotaxin-1) with Psychiatric Comorbidity.

Authors:  Nuria García-Marchena; Pedro Fernando Araos; Vicente Barrios; Laura Sánchez-Marín; Julie A Chowen; María Pedraz; Estela Castilla-Ortega; Pablo Romero-Sanchiz; Guillermo Ponce; Ana L Gavito; Juan Decara; Daniel Silva; Marta Torrens; Jesús Argente; Gabriel Rubio; Antonia Serrano; Fernando Rodríguez de Fonseca; Francisco Javier Pavón
Journal:  Front Psychiatry       Date:  2017-01-18       Impact factor: 4.157

7.  Serum Cytokines Predict Neurological Damage in Genetically Diverse Mouse Models.

Authors:  Aracely A Pérez Gómez; Moumita Karmakar; Raymond J Carroll; Koedi S Lawley; Katia Amstalden; Colin R Young; David W Threadgill; C Jane Welsh; Candice Brinkmeyer-Langford
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

8.  Baseline levels and temporal stability of 27 multiplexed serum cytokine concentrations in healthy subjects.

Authors:  Angelique Biancotto; Abigail Wank; Shira Perl; Wendell Cook; Matthew J Olnes; Pradeep K Dagur; J Christopher Fuchs; Marc Langweiler; Ena Wang; J Philip McCoy
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240

9.  Eotaxin levels in patients with primary dysmenorrhea.

Authors:  Evrim Gul; Ebru Celik Kavak
Journal:  J Pain Res       Date:  2018-03-23       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.